Immuno-oncology firm Batu Biologics is developing universal donor therapies targeting multiple pathways to enhance efficacy & specificity of cancer treatments
@Immuneadvisors Yeah it blocks neuropilin the potent angiogenic molecule that also is on Tregs ...now you see why it's important to #starvethetumor
$nk